Companies: 10,795·Total market cap: $144.5T
Organon & Co.

Organon & Co.

OGNNYSEHealthcare● Active
$13.39
+$0.03(+0.19%)
Market Cap$3.5B
P/E Ratio—
52W High$13.48
52W Low$5.69
Shares OutstandingFinancialsRevenue

Organon & Co. (OGN) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

OGN · shares outstanding · updated Jun 8, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
259.5M▲ +0.95% YoY Change
FY · as of Dec 31, 2025 · Reported in USD
vs 257.0M in FY 2024
Diluted Shares Outstanding
260.8M
incl. options, RSUs, convertibles
Dilution Spread
+0.49%
Diluted vs Basic
YoY Change
+0.95%
year-over-year
Float (Free Float)
261.1M
publicly tradable shares
99.4% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-08

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+0.7%
2022 → 2025
5-Year CAGRincreasing
+0.5%
2020 → 2025
10-Year CAGR—
—
—
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2025Latest
Diluted Shares: 260.8M
259.5M
+0.95%
FY 2024
Diluted Shares: 259.2M
257.0M
+0.71%
FY 2023
Diluted Shares: 256.3M
255.2M
+0.46%
FY 2022
Diluted Shares: 255.2M
254.1M
+0.21%
FY 2021
Diluted Shares: 253.6M
253.6M
+0.01%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs OGN
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+864.2%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+835.9%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+586.1%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+497.3%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+250.7%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+246.1%
#7
Organon & Co.OGN
Organon & Co.YOU
259.5M—

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Organon & Co. (OGN) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2025, Organon & Co. reports 259.5M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Organon & Co.'s basic shares outstanding (259.5M) represents currently issued shares. Diluted shares outstanding (260.8M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.49%.

Shares Outstanding vs. Float (Free Float)

Organon & Co.'s float is 261.1M (99.4% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float261.1M(99.4%)
Outstanding262.6M

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

Organon & Co. (OGN) shares outstanding history from 2017 to 2025. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Organon & Co. shares outstanding for the fiscal year ending December 31, 2025 were 259.5M, a 0.95% increase year-over-year. Organon & Co. FY 2025 shares outstanding were 259.5M, a +0.95% increase from FY 2024.

Organon & Co. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of — — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

OGN shares outstanding · 4 questions

As of December 31, 2025, Organon & Co. (OGN) has approximately 259.5M basic shares outstanding and 260.8M diluted shares outstanding. This represents a +0.95% year-over-year increase from FY 2024 (257.0M). The increase may reflect equity compensation issuances or secondary offerings.

OGN shares outstandinghow many shares does OGN haveOGN basic shares 2025OGN diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Organon & Co. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-08